Research publications

Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis

Aspinall EJ, Corson S, Doyle JS, Grebely J, Hutchinson SJ, Dore GJ, Goldberg DJ, Hellard ME

(2013), Clin Infect Dis, 57 Suppl 2, S80-9

Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome

Chang CC, Omarjee S, Lim A, Spelman T, Gosnell BI, Carr WH, Elliott JH, Moosa MY, Ndung'u T, French MA, Lewin SR

(2013), J Infect Dis, 208(10), 1604-12

Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect

Grund B, Wright EJ, Brew BJ, Price RW, Roediger MP, Bain MP, Hoy JF, Shlay JC, Vjecha MJ, Robertson KR; INSIGHT SMART Study Group

(2013), J Neurovirol, 19(4), 383-92

Are Australian sexual health clinics attracting priority populations?

Ali H, Donovan B, Fairley CK, Ryder N, McNulty A, Chen MY, Marshall L, O'Connor CC, Dickson B, Grulich AE, Hellard ME, Kaldor JM, Guy RJ; ACCESS Collaboration

(2013), Sex Health, 10(5), 456-9

Opt-out and opt-in testing increases syphilis screening of HIV-positive men who have sex with men in Australia

Guy R, El-Hayek C, Fairley CK, Wand H, Carr A, McNulty A, Hoy J, Bourne C, McAllister J, Tee BK, Baker D, Roth N, Stoove M, Chen M

(2013), PLoS One, 8(8), e71436

Quantifying current hepatitis C virus incidence in Egypt – response to letter by Miller and Abu-Raddad

Breban R, Doss W, Esmat G, Elsayed M, Hellard M, Ayscue P, Albert M, Fontanet A, Mohamed MK

(2013), J Viral Hepat, 20(9), 668

Tissue dendritic cells as portals for HIV entry

Harman AN, Kim M, Nasr N, Sandgren KJ, Cameron PU

(2013), Rev Med Virol, 23(5), 319-33

IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling

Li S, Lefranc MP, Miles JJ, Alamyar E, Giudicelli V, Duroux P, Freeman JD, Corbin VD, Scheerlinck JP, Frohman MA, Cameron PU, Plebanski M, Loveland B, Burrows SR, Papenfuss AT, Gowans EJ

(2013), Nat Commun, 4, 2333

Increasing access by priority populations to Australian sexual health clinics

Ali H, Donovan B, Fairley CK, Chen MY, O'Connor CC, Grulich AE, McNulty A, Ryder N, Hellard ME, Guy RJ; ACCESS Collaboration

(2013), Sex Transm Dis, 40(10), 819-21

Pustular skin lesions in a patient with advanced HIV infection and pneumonia

Macesic N, Chang C, Abbott IA, Trevillyan J, Pham A, Lewin SR

(2013), Clin Infect Dis, 57(8), 1210-1

A polymorphism in IL4 may associate with sensory neuropathy in African HIV patients

Wadley AL, Kamerman PR, Chew CS, Lombard Z, Cherry CL, Price P

(2013), Mol Immunol, 55(3-4), 197-9

The end of AIDS: HIV infection as a chronic disease

Deeks SG, Lewin SR, Havlir DV

(2013), Lancet, 382(9903), 1525-3

Australian prescribers' perspectives on ART initiation in the era of "treatment as prevention"

Mao L, de Wit J, Adam P, Post JJ, Crooks L, Kidd MR, Slavin S, Kippax S, Wright E

(2013), AIDS Care, 25(11), 1375-9

Hepatitis C transmission and treatment in contact networks of people who inject drugs

Rolls DA, Sacks-Davis R, Jenkinson R, McBryde E, Pattison P, Robins G, Hellard M

(2013), PLoS One, 8(11), e78286

Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells

Wightman F, Lu HK, Solomon AE, Saleh S, Harman AN, Cunningham AL, Gray L, Churchill M, Cameron PU, Dear AE, Lewin SR

(2013), AIDS, 27(18), 2853-62

High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study

Sacks-Davis R, Aitken CK, Higgs P, Spelman T, Pedrana AE, Bowden S, Bharadwaj M, Nivarthi UK, Suppiah V, George J, Grebely J, Drummer HE, Hellard M

(2013), PLoS One, 8(11), e80216

Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection

Feld JJ, Grebely J, Matthews GV, Applegate T, Hellard M, Sherker A, Cherepanov V, Petoumenos K, Yeung B, Kaldor JM, Lloyd AR, Dore GJ

(2013), PLoS One, 8(11), e80003

An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients

Spina CA, Anderson J, Archin NM, Bosque A, Chan J, Famiglietti M, Greene WC, Kashuba A, Lewin SR, Margolis DM, Mau M, Ruelas D, Saleh S, Shirakawa K, Siliciano RF, Singhania A, Soto PC, Terry VH, Verdin E, Woelk C, Wooden S, Xing S, Planelles V

(2013), PLoS Pathog, 9(12), e1003834

Myeloid dendritic cells induce HIV-1 latency in non-proliferating CD4+ T cells

Evans VA, Kumar N, Filali A, Procopio FA, Yegorov O, Goulet JP, Saleh S, Haddad EK, da Fonseca Pereira C, Ellenberg PC, Sekaly RP, Cameron PU, Lewin SR

(2013), PLoS Pathog, 9(12), e1003799

Acquisition of HIV by African-born residents of Victoria, Australia: insights from molecular epidemiology

Lemoh C, Ryan CE, Sekawi Z, Hearps AC, Aleksic E, Chibo D, Grierson J, Baho S, Street A, Hellard M, Biggs BA, Crowe SM

(2013), PLoS One, 8(12), e84008

Publication Details